Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, options, and ETFs commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. 

CEO
Paul Hudson
CEOPaul Hudson
Employees
87,994
Employees87,994
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
87,994
Employees87,994

SNY Key Statistics

Market cap
123.79B
Market cap123.79B
Price-Earnings ratio
20.87
Price-Earnings ratio20.87
Dividend yield
2.83%
Dividend yield2.83%
Average volume
1.73M
Average volume1.73M
High today
$48.67
High today$48.67
Low today
$48.31
Low today$48.31
Open price
$48.61
Open price$48.61
Volume
613.72K
Volume613.72K
52 Week high
$55.72
52 Week high$55.72
52 Week low
$42.63
52 Week low$42.63

SNY News

Yahoo Finance 2d
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers - Yahoo Finance

For Immediate Release Chicago, IL – May 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ana...

The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers - Yahoo Finance
Yahoo Finance 2d
Could Novavax Become the Next Moderna? - Yahoo Finance

Novavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soare...

Could Novavax Become the Next Moderna? - Yahoo Finance
Benzinga 3d
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pha...

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

Analyst ratings

83%

of 24 ratings
Buy
83.3%
Hold
12.5%
Sell
4.2%

More SNY News

Yahoo Finance 4d
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction? - Yahoo Finance

Monthly Charts of Novavax (NVAX) and Sanofi ARD (SNY) – Source: ActivTrader This news sent a shockwave through the market, rewarding both long-term holders and...

Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction? - Yahoo Finance
Investor's Business Daily 5d
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?

Novavax (NVAX) stock nearly tripled over two days in May after inking a roughly $1.3 billion licensing deal with Sanofi (SNY) for its Covid vaccine. X Under t...

Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Yahoo Finance 5d
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? - Yahoo Finance

Shares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday, May 10. The market was responding to terrific news from Sanofi...

Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? - Yahoo Finance
Simply Wall St 5d
Exploring Three Dividend Stocks On Euronext Paris

Amidst a backdrop of rising optimism in European markets, where indices like France's CAC 40 have recently seen significant gains, investors are increasingly at...

Exploring Three Dividend Stocks On Euronext Paris
Yahoo Finance 5d
Innate Pharma Reports First Quarter 2024 Business Update and Financial Results - Yahoo Finance

First preclinical data set for IPH45, a pre-IND anti-Nectin-4 Antibody Drug Conjugate, presented as an oral presentation at AACR 2024 Progression of Sanofi-dev...

Innate Pharma Reports First Quarter 2024 Business Update and Financial Results - Yahoo Finance
TipRanks 5d
Novavax Explodes 50% Higher after Sanofi Deal - TipRanks.com - TipRanks

Today was huge for Novavax (NASDAQ:NVAX), as the vaccine producer revealed a new deal with Sanofi (NASDAQ:SNY). The move was an unqualified winner as far as sha...

CNBC 5d
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker

Shares of Novavax jumped as much as 50% on Monday as Wall Street cheered the company's new multibillion-dollar deal with French drugmaker Sanofi that sparked a...

Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.